Here are five updates on GI companies from the past week:
Motus GI named Jeff Hutchison vice president of U.S. sales and commercial operations.
Motus GI released its second quarter 2018 financial results, posting a $4.2 million net loss, or $0.27 per diluted share.
Exact Sciences, the manufacturer of Cologuard, and the Green Bay Packers launched "Crossing the 50," a new campaign to raise money for the Vince Lombardi Cancer Foundation.
Miami-based Gastro Health made a series of leadership appointments as the practice continues to expand.
The FDA awarded Array Biopharma's mutant metastatic colorectal cancer treatment the breakthrough therapy designation.